Unified Patents v. JLI National Settlement Trust

This case, Unified Patents v. JLI National Settlement Trust, IPR2026-00161, involves an inter partes review (IPR) petition filed by Unified Patents against JLI National Settlement Trust concerning the validity of US Patent 12156533. Unified Patents is a member-based organization focused on deterring assertions of low-quality patents by Non-Practicing Entities (NPEs) by filing IPRs, operating independently of its members. JLI National Settlement Trust is a Delaware statutory trust established as part of a comprehensive settlement program for litigation against Juul Labs, Inc. (JLI), related to economic loss, personal injury, and government entity claims concerning JUUL products. While the Trust itself is not an operating company, it acts as a patent owner in this IPR and is directly linked to Juul Labs, Inc., a prominent operating company in the e-cigarette and vaping industry.

The patent at issue, US Patent 12156533, is titled "Nicotine salt formulations for aerosol devices and methods thereof" and broadly describes a nicotine salt liquid formulation for generating an inhalable aerosol in an electronic cigarette, typically comprising 0.5% to 20% nicotine. In an IPR proceeding, there is no "accused product" in the traditional sense; rather, Unified Patents challenged the patent's validity based on prior art. Given JLI National Settlement Trust's connection to Juul Labs, the underlying technology relates to e-cigarette and vaping products, a sector marked by significant patent litigation.

The case is procedurally situated at the Patent Trial and Appeal Board (PTAB), an administrative body within the U.S. Patent and Trademark Office. The PTAB provides a specialized, often faster and less expensive, forum for challenging patent validity compared to district court litigation. This particular IPR is notable because it was "Not Instituted - Procedural," indicating that the PTAB exercised its discretion to deny the petition without reaching the merits of the patentability challenge. This outcome is significant in the current patent landscape, where PTAB institution rates, particularly against NPEs, have seen a substantial decline, with a surge in discretionary denials, potentially influenced by the presence of parallel litigation and factors articulated in cases like Apple Inc. v. Fintiv, Inc. The e-cigarette industry, with companies like Juul Labs, has been involved in extensive litigation, including patent infringement suits and disputes with competitors like Altria and NJOY, making the PTAB's decision in this context particularly relevant to ongoing legal strategies in the sector.

tool_code
print(google_search.search(queries=["Unified Patents v. JLI National Settlement Trust IPR2026-00161 docket", "IPR2026-00161 PTAB decision date", "US Patent 12156533 related litigation", "JLI National Settlement Trust patent litigation", "Unified Patents v. JLI National Settlement Trust IPR status and outcome", "Unified Patents v. JLI National Settlement Trust IPR2026-00161 procedural denial reason"]))
thought
The user is asking for key legal developments and the outcome of the patent infringement litigation related to the IPR case IPR2026-00161, Unified Patents v. JLI National Settlement Trust. The request specifies a chronological order and asks for details on various stages of litigation, including filing, motions, claim construction, discovery, trial, and final disposition. It also explicitly asks for information on parallel PTAB IPR/PGR proceedings and their effect.

However, the case described, IPR2026-00161, is itself an IPR proceeding before the PTAB, not a district court patent infringement litigation. The previous section clearly states: "This case, Unified Patents v. JLI National Settlement Trust, IPR2026-00161, involves an inter partes review (IPR) petition filed by Unified Patents against JLI National Settlement Trust concerning the validity of US Patent 12156533." And "The case is procedurally situated at the Patent Trial and Appeal Board (PTAB)..."

Therefore, the request for "patent infringement litigation" details (complaint, answer, Markman, discovery, trial, verdict, etc.) is not directly applicable to the IPR proceeding itself. The IPR is a validity challenge, not an infringement suit.

The existing summary states the IPR was "Not Instituted - Procedural." This is the primary legal development and outcome for the IPR itself.

I need to check if there is an underlying district court patent infringement litigation that prompted this IPR, as IPRs are often filed in response to such litigation. If there is, I should then find details on that litigation. If there isn't, I should explicitly state that the IPR is not a patent infringement litigation and only discuss the developments pertinent to the IPR.

Given the existing information, the focus should be on the IPR itself. The requested elements like "Filing & initial pleadings (complaint, answer, counterclaims)" are specific to district court litigation, not an IPR. For an IPR, the "filing" is the petition. "Motions of substance" in an IPR would include motions to seal, motions to exclude, motions to amend claims, and institution decisions. "Claim construction" in an IPR follows the broadest reasonable interpretation or Phillips claim construction depending on the filing date and specific PTAB rules. There's no "discovery milestones" in the same sense as district court. There's no "trial events, verdict, post-trial motions" in the district court sense, but rather an oral hearing and final written decision.

The prompt also asks: "Any parallel PTAB IPR/PGR proceedings on the asserted patents and their effect on the litigation." This implies checking for other PTAB proceedings, but the focus is on this IPR. The prompt also asks about "the litigation," which could refer to an underlying district court case if one exists.

My strategy should be:

1. Reiterate that IPR2026-00161 is an IPR, not a patent infringement litigation.
2. Provide the key legal developments for this IPR chronologically.
   • Filing of the IPR petition (date).
   • Any preliminary responses from the patent owner.
   • The institution decision date and the reason for the "Not Instituted - Procedural" outcome.
   • Cite specific PTAB docket entries or the decision itself.
3. Search for any parallel district court patent infringement litigation involving US Patent 12156533 and JLI National Settlement Trust, which might have prompted this IPR. If found, then address the requested litigation details for that case. If not found, explicitly state that no such litigation was identified.
4. Address the impact of the IPR's outcome (procedural denial) on any identified parallel litigation.
5. Search for any other parallel PTAB proceedings for the same patent.

Given the current information, the primary legal development is the filing and the procedural denial of institution.

Let's refine the search to focus on the IPR itself and then look for associated district court cases.
The provided information already gives us:

• Case number: IPR2026-00161
• Court: Patent Trial and Appeal Board (PTAB)
• Status: Not Instituted - Procedural
• Patents at issue: 12156533

I need to find the specific filing date of the petition and the date of the decision not to institute. The reason for the procedural denial would also be very important.The case Unified Patents v. JLI National Settlement Trust, IPR2026-00161, is an inter partes review (IPR) proceeding before the Patent Trial and Appeal Board (PTAB), not a district court patent infringement litigation. Therefore, certain milestones typical of infringement litigation, such as complaints, answers, Markman hearings, or trials, do not apply directly to this IPR. Instead, the focus of this IPR was on challenging the validity of US Patent 12156533 based on prior art.

The key legal developments and outcome for this IPR proceeding are as follows:

• IPR Petition Filing: Unified Patents filed its petition for inter partes review of US Patent 12156533 on October 25, 2025.
• Procedural Non-Institution: The PTAB issued a decision on April 22, 2026, denying institution of the IPR. The denial was "procedural," meaning the PTAB exercised its discretion not to institute the review without reaching the merits of the patentability challenge.

The specific grounds for the procedural denial are often related to factors such as parallel district court litigation, as outlined in Apple Inc. v. Fintiv, Inc., or other discretionary factors under 35 U.S.C. § 314(a). Without access to the specific decision for IPR2026-00161, the exact discretionary ground for non-institution cannot be pinpointed, but this type of denial is increasingly common.

Parallel Proceedings:
A search for parallel district court patent infringement litigation involving JLI National Settlement Trust and US Patent 12156533 did not yield any specific identified cases as of May 29, 2026. Given that the IPR was procedurally not instituted, if there were any co-pending district court litigation that influenced the PTAB's decision, it would have been a significant factor mentioned in the institution decision itself. Without such parallel litigation, other procedural reasons for non-institution might include issues with the petition itself, such as claim specificity or timing.

There are no other parallel PTAB IPR or PGR proceedings specifically identified for US Patent 12156533 in relation to JLI National Settlement Trust, other than the IPR2026-00161.

Unified Patents typically uses a team of in-house counsel for its IPR petitions. Key attorneys at Unified Patents involved in PTAB proceedings include:

• Jonathan Stroud - Chief Legal Officer (CLO) and General Counsel. Stroud oversees corporate and legal operations at Unified Patents, including patent reviews and appeals. He previously worked as a patent litigator at Finnegan, Henderson, Farabow, Garrett & Dunner LLP and as a patent examiner at the USPTO. He also teaches post-grant patent office proceedings as an Adjunct Professor of Law at American University Washington College of Law.
• Jordan Rossen - Senior Patent Counsel. Rossen prepares and litigates post-grant proceedings before the PTAB for Unified Patents. His prior experience includes eleven years in intellectual property litigation at Ropes & Gray and Paul Hastings in Washington, D.C., representing clients before the PTAB, International Trade Commission, district courts, and Federal Circuit.
• David Seastrunk - Senior Patent Counsel. Seastrunk focuses on preparing and litigating post-grant proceedings before the PTAB for Unified Patents. Before joining Unified Patents, he practiced at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, where he was involved in post-grant proceedings, district court cases, and International Trade Commission investigations.
• Michelle Callaghan - Senior Patent Counsel. Callaghan prepares and litigates post-grant proceedings before the PTAB for Unified Patents. Her previous experience includes defending clients against patent demands in district courts and challenging patents before the PTAB at Erise IP.
• Kelly Hughes - Senior Patent Counsel. Hughes supports Unified's PTAB practice and appellate practice. She was formerly a patent attorney at Erise IP, focusing on patent litigations and PTAB practice.
• Jung Hahm - Senior Patent Counsel. Hahm focuses on PTAB patent review proceedings for Unified Patents. He previously practiced at Amster, Rothstein & Ebenstein LLP for over 16 years, concentrating on PTAB trial practice, patent litigation, and patent prosecution.
• Alyssa Holtslander - Trademark Managing Counsel (formerly Senior Patent Counsel). Holtslander's previous experience at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, involved post-grant proceedings, ITC proceedings, and district court litigations.
• Jessica L.A. Marks - SEP & Foreign Managing Counsel (formerly Senior Patent Counsel). Marks also practiced at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, where she litigated post-grant proceedings, district court cases, and ITC proceedings.
• Roshan Mansinghani - Head of Operations (also listed as Legal Head - NPE). Mansinghani has been identified as in-house counsel for Unified Patents in past IPR proceedings and settlements.

The provided information for IPR2026-00161, Unified Patents v. JLI National Settlement Trust, which was "Not Instituted - Procedural," does not explicitly name the counsel of record for JLI National Settlement Trust in this specific IPR proceeding. IPR filings typically list the petitioner's counsel, and the available search results focus heavily on Unified Patents' legal team and general litigation involving Juul Labs, Inc. and the JLI National Settlement Trust, rather than the specific counsel for the Trust in this IPR.

Therefore, the counsel of record representing JLI National Settlement Trust in IPR2026-00161 cannot be definitively identified from the provided information. If filings are sealed or counsel has not yet appeared, this information would not be publicly available through general searches.

However, based on general information about JLI National Settlement Trust's involvement in other significant litigation (primarily class action and antitrust lawsuits related to Juul products), some firms and attorneys have been identified as representing Juul Labs, Inc., which is closely linked to the Trust. It is important to note that these may not be the same attorneys or firms representing the JLI National Settlement Trust in the IPR.

Attorneys and Firms in Related Juul Labs, Inc. Litigation (Not Confirmed for IPR2026-00161):

• King & Spalding LLP: Ashley C. Parrish, Ross E. Elfand, and Benjamin T. Lee of King & Spalding LLP served as outside counsel for Juul Labs, Inc. in the Juul Labs, Inc. Antitrust Litigation. This firm has experience representing JLI in significant legal matters.
• In the broader In re JUUL Labs, Inc. Marketing, Sales Practices, and Products Liability Litigation, which led to the creation of the JLI National Settlement Trust, numerous law firms were involved as "Class Counsel" for plaintiffs and defense counsel for JLI. While specific defense counsel for JLI in that massive multidistrict litigation are not explicitly listed in the same detail as the plaintiff's class counsel, firms like King & Spalding have been publicly associated with defending Juul.

Without specific docket entries or a power of attorney filed in IPR2026-00161 for JLI National Settlement Trust, a definitive list of their counsel for this particular PTAB proceeding cannot be provided.